These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36502736)

  • 1. Primary endometrial gastric (gastro-intestinal)-type carcinoma: A practical approach.
    Dridi M; Peoc'h M; Karpathiou G
    Pathol Res Pract; 2023 Jan; 241():154271. PubMed ID: 36502736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous Proliferations of the Uterine Corpus: Comprehensive Appraisal of an Evolving Spectrum of Neoplasms.
    Fadare O
    Adv Anat Pathol; 2022 Sep; 29(5):275-296. PubMed ID: 35499137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrioid adenocarcinoma with simultaneous endocervical and intestinal-type mucinous differentiation: report of a rare phenomenon and the immunohistochemical profile.
    Buell-Gutbrod R; Sung CJ; Lawrence WD; Quddus MR
    Diagn Pathol; 2013 Aug; 8():128. PubMed ID: 23915109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal‑type mucinous carcinoma of the endometrium showing a polypoidal exophytic form: A case report.
    Nakano C; Fukuda T; Tanaka S; Noda T; Uchikura E; Awazu Y; Tasaka R; Imai K; Yamauchi M; Ichimura T; Yasui T; Sumi T
    Oncol Lett; 2023 Oct; 26(4):444. PubMed ID: 37720664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
    Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
    Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
    Tambouret R; Clement PB; Young RH
    Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric-type endocervical adenocarcinoma with uterine corpus involvement mimicking primary endometrial carcinoma.
    Kamiya A; Ikura Y; Iizuka N; Yokokawa T; Kato H; Oishi T
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1414-1417. PubMed ID: 31012190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma.
    Elfeky M; Harb O; Gertallah L
    Turk Patoloji Derg; 2017; 1(1):29-40. PubMed ID: 28832070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous occurrence of primary neoplasms of the uterus with mucinous carcinoma of the cervix and endometrioid carcinoma of the endometrium.
    Sun HD; Lai CR; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):377-8. PubMed ID: 22030058
    [No Abstract]   [Full Text] [Related]  

  • 15. Synchronous clear cell adenocarcinoma of the cervix and endometrioid carcinoma of the endometrium.
    Park ST; Song MJ; Lee CW; Lee AW; Hur SY; Park JS
    Eur J Gynaecol Oncol; 2011; 32(5):573-5. PubMed ID: 22053679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endometrium.
    Silverberg SG
    Arch Pathol Lab Med; 2007 Mar; 131(3):372-82. PubMed ID: 17516740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic detection of cervical and endometrial carcinoma with other genital tract involvement.
    Kobilková J; Lojda Z; Dohnalová A; Havránková E
    Acta Cytol; 2000; 44(1):13-7. PubMed ID: 10667153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
    Taylor J; McCluggage WG
    Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
    Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E
    BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.